References
- El-Darouti MA, Marzouk SA, Azzam O, Fawzi MM, Abdel-Halim MR, Zayed AA, et al. Vitiligo vs hypopigmented mycosis fungoides. Eur J Dermatol. 2006;16:17–22.
- Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg. 2009;28:86–92.
- Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet. 1994;55:981–990.
- Bam M, Bagchi T. Absence of tyrosinase-related protein- 2/dopachrome tautomerase transcripts in PBMCs from vitiligo patients. Scand J Immunol. 2009;69:366–373.
- Minashkin MM, Salnikova LE, Lomonosov KM, Korobko IV, Tatarenko AO. Possible contribution of GSTP1 and other xenobiotic metabolizing genes to vitiligo susceptibility. Arch Dermatol Res. 2013;305:233–239.
- Bakry OA, Hammam MA, Wahed MM. Immunohistochemical detection of P53 and Mdm2 in vitiligo. Indian Dermatol Online J. 2012;3:171–176.
- Halder RM. Vitiligo. In: Wolff K, Freedberg IM, Fitzpatrick TB, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York: McGraw-Hill Professional; 2007.
- Lee KY, Jeon SY, Hong JW, Choi KW, Lee CY, Choi SJ, et al. Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. J Eur Acad Dermatol Venereol. 2013;27:609–616.
- Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol. 2002;46:727–731.
- Elliott JA Jr. Clinical experiences with methoxsalen in the treatment of vitiligo. J Invest Dermatol. 1959;32: 311–314.
- Farah F, Kurban A, Chaglassian H. The treatment of vitiligo with psoralens and triamcinolone by mouth. Br J Dermatol. 1967;79:89–91.
- Ortonne J. Psoralen therapy in vitiligo. Clin Dermatol. 1989;7:120–135.
- Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. Br J Dermatol. 2012;167: 468–478.
- Baltás E, Nagy P, Bonis B, Novák Z, Ignácz F, Szabó G, et al. Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol. 2001;144:1266–1267.
- de With A, Greulich KO. Wavelength dependence of laser- induced DNA damage in lymphocytes observed by single-cell gel electrophoresis. J Photochem Photobiol B. 1995;30:71–76.
- Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriaticlesions. J Exp Med. 1999;189;711–718.
- Noborio R, Kobayashi K, Shintani Y, Morita A. Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2006;22:262–264.
- Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140:1065–1069.
- Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130–135.
- Passeron T, Ortonne JP. The 308 nm excimer laser in dermatology. Presse Med. 2005;34:301–309.
- Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A. Response of vitiligo to once -vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blined trial. J Eur Acad Dermatol Venereol. 2009;23:951–953.
- Al-Otaibi SR, Zadeh VB, Al-Abdulrazzaq AH, Tarrab SM, Al-Owaidi HA, Mahrous R, et al. Using a 308-nm excimer laser to treat vitiligo in Asians. Acta Dermatovenerol Alp Panonica Adriat. 2009;18:13–19.
- Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004:140:677–683.
- Alhowaish AK, Dietrich N, Onder M, Fritz K. Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review. Lasers Med Sci. 2013;28:1035–1041.
- Kathuria S, Khaitan BK, Ramam M, Sharma VK. Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream. Indian J Dermatol Venereol Leprol. 2012;78:68–73.